Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system

Progress in Brain Research

Volumn 145, Issue , 2004, Pages 233-251

  Champtiaux, Nicolas ^a   Changeux, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Addiction; Aging; Alzheimer's disease; Analgesia; Attention; Cognition; Development; Dopaminergic; Knockin; Knockout; Neurodegeneration; Nicotinic receptors; Reinforcement; Schizophrenia

Indexed keywords

5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; ALPHA BUNGAROTOXIN; BRAIN RECEPTOR; COCAINE; CONOTOXIN; CYTISINE; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; MECAMYLAMINE; METHYLLYCACONITINE; MORPHINE; NEUROTRANSMITTER RECEPTOR; NEW DRUG; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT;

AGING; ALZHEIMER DISEASE; ANALGESIC ACTIVITY; APOPTOSIS; ATTENTION DEFICIT DISORDER; BEHAVIOR; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN FUNCTION; CELL DEATH; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; CORRELATION ANALYSIS; DEMENTIA; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EPILEPSY; EXPERIMENTAL MODEL; GENETIC ENGINEERING; HOT PLATE TEST; HUMAN; KNOCKOUT MOUSE; MAZE TEST; MEMORY DISORDER; MOTOR PERFORMANCE; MUTANT; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OPTIC TRACT; PAIN; PARKINSON DISEASE; PASSIVE AVOIDANCE; PATHOLOGY; PLACE PREFERENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REINFORCEMENT; RETINA GANGLION CELL; REWARD; SCHIZOPHRENIA; SENSORY CORTEX; SMOKING CESSATION; SOCIAL BEHAVIOR; STARTLE REFLEX; TASK PERFORMANCE; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

EID: 0344441256     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(03)45016-4     Document Type: Conference Paper

References (134)

1. Acri, J.B., Morse, D.E., Popke, E.J. and Grunberg, N.E. (1994) Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology (Berl.), 114: 369-374.
2. Aubert, I., Araujo, D.M., Cecyre, D., Robitaille, Y., Gauthier, S. and Quirion, R. (1992) Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem., 58: 529-541.
3. Bannon, A.W., Decker, M.W., Holladay, M.W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P.S., Bitner, R.S., Diaz, A., Dickenson, A.H., Porsolt, R.D., Williams, M., Arneric, S.P. (1998) Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science, 279: 77-81.
4. Bansal, A., Singer, J.H., Hwang, B.J., Xu, W., Beaudet, A. and Feller, M.B. (2000) Mice lacking specific nicotinic acetylcholine receptor subunits exhibit dramatically altered spontaneous activity patterns and reveal a limited role for retinal waves in forming ON and OFF circuits in the inner retina. J. Neurosci., 20: 7672-7681.
5. Belluardo, N., Mudo, G., Blum, M., Amato, G. and Fuxe, K. (2000) Neurotrophic effects of central nicotinic receptor activation. J. Neural. Transm. Suppl.(60): 227-245.
6. Berger, F., Gage, F.H. and Vijayaraghavan, S. (1998) Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. J. Neurosci., 18: 6871-6881.
7. Berridge, K.C. and Robinson, T.E. (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Res. Brain Res. Rev., 28: 309-369.
8. Bertrand, D. (1999) Neuronal nicotinic acetylcholine receptors: their properties and alterations in autosomal dominant nocturnal frontal lobe epilepsy. Rev. Neurol. (Paris), 155: 457-462.
9. Bertrand, D., Devillers-Thiery, A., Revah, F., Galzi, J.L., Hussy, N., Mulle, C., Bertrand, S., Ballivet, M. and Changeux, J.P. (1992) Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc. Natl. Acad. Sci. USA, 89: 1261-1265.
10. Bertrand, D., Galzi, J.L., Devillers-Thiery, A., Bertrand, S. and Changeux, J.P. (1993) Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc. Natl. Acad. Sci. USA. 90: 6971-6975.
11. Bina, K.G., Guzman, P., Broide, R.S., Leslie, F.M., Smith, M.A. and O'Dowd, D.K. (1995) Localization of alpha 7 nicotinic receptor subunit mRNA and alpha-bungarotoxin binding sites in developing mouse somatosensory thalamocortical system. J. Comp. Neurol., 363: 321-332.
12. Booker, T.K., Allen, R.S., Marks, M.J., Grady, S.R., Whiteaker, P., Smith, K.W., Collins, A.C. and Heinemann, S.F. (1999) In: Neuronal Nicotinic Receptors: From Structure to Therapeutics, Venice, p. 22.
13. Braff, D.L., Geyer, M.A. and Swerdlow, N.R. (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl.), 156: 234-258.
14. Broide, R.S. and Leslie, F.M. (1999) The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol. Neurobiol., 20: 1-16.
15. Broide, R.S., O'Connor, L.T., Smith, M.A., Smith, J.A. and Leslie, F.M. (1995) Developmental expression of alpha 7 neuronal nicotinic receptor messenger RNA in rat sensory cortex and thalamus. Neuroscience, 67: 83-94.
16. Broide, R.S., Orr-Urtreger, A. and Patrick, J.W. (2001) Normal apoptosis levels in mice expressing one alpha7 nicotinic receptor null and one L250T mutant allele. Neuroreport, 12: 1643-1648.
17. Caldarone, B.J., Duman, C.H. and Picciotto, M.R. (2000) Fear conditioning and latent inhibition in mice lacking the high affinity subclass of nicotinic acetylcholine receptors in the brain. Neuropharmacology, 39: 2779-2784.
18. Cartier, G.E., Yoshikami, D., Gray, W.R., Luo, S., Olivera, B.M.and and McIntosh, J.M. (1996) A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J. Biol. Chem., 271: 7522-7528.
19. Castro, N.G. and Albuquerque, E.X. (1995) alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys. J., 68: 516-524.
20. Champtiaux, N., Han, Z.Y., Bessis, A., Rossi, F.M., Zoli, M., Marubio, L., McIntosh, J.M. and Changeux, J.P. (2002) Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J. Neurosci., 2: 1208-1217.
21. Chan, J. and Quik, M. (1993) A role for the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC12 cells. Neuroscience, 56: 441-451.
22. Chappell, J., McMahan, R., Chiba, A. and Gallagher, M. (1998) A re-examination of the role of basal forebrain cholinergic neurons in spatial working memory. Neuropharmacology, 37: 481-487.
23. Conroy, W.G. and Berg, D.K. (1995) Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem., 270: 4424-4431.
24. Conroy, W.G. and Berg, D.K. (1998) Nicotinic receptor subtypes in the developing chick brain: appearance of a species containing the alpha4, beta2, and alpha5 gene products. Mol. Pharmacol., 53: 392-401.
25. Cordero-Erausquin, M. and Changeux, J.P. (2001) Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl. Acad. Sci. USA, 98: 2803-2807.
26. Corrigall, W.A., Coen, K.M. and Adamson, K.L. (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res., 653: 278-284.
27. Corrigall, W.A., Coen, K.M., Zhang, J. and Adamson, K.L. (2001) GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology (Berl.), 158: 190-197.
28. Corringer, P.J., Le Novere, N. and Changeux, J.P. (2000) Nicotinic receptors at the amino acid level. Annu. Rev. Pharmacol. Toxicol., 40: 431-458.
29. Curtis, L., Blouin, J.L., Radhakrishna, U., Gehrig, C., Lasseter, V.K., Wolyniec, P., Nestadt, G., Dombroski, B., Kazazian, H.H., Pulver, A.E., Housman, D., Bertrand, D., Antonarakis, S.E. (1999) No evidence for linkage between schizophrenia and markers at chromosome 15q13-14. Am. J. Med. Genet., 88: 109-112.
30. Curzon, P., Kim, D.J. and Decker, M.W. (1994) Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat. Pharmacol. Biochem. Behav., 49: 877-882.
31. Dani, J.A. and Heinemann, S. (1996) Molecular and cellular aspects of nicotine abuse. Neuron, 16: 905-908.
32. Decker, M.W., Bannon, A.W., Curzon, P., Gunther, K.L., Brioni, J.D., Holladay, M.W., Lin, N.H., Li, Y., Daanen, J.F., Buccafusco, J.J., Prendergast, M.A., Jackson, W.J., Arneric, S.P. (1997) ABT-089 [2-methyl-3-(2-(S)-pyrrolidinyl-methoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. J. Pharmacol. Exp. Ther., 283: 247-258.
33. Decker, M.W., Majchrzak, M.J. and Anderson, D.J. (1992) Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res., 572: 281-285.
34. Dehaene, S. and Changeux, J.P. (2000) Reward-dependent learning in neuronal networks for planning and decision making. Prog. Brain Res., 126: 217-229.
35. Della Casa, V., Hofer, I. and Feldon, J. (1999) Latent inhibition in smokers vs. nonsmokers: interaction with number or intensity of preexposures?. Pharmacol. Biochem. Behav., 62: 353-359.
36. Di Chiara, G. (1998) A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J. Psychopharmacol., 12: 54-67.
37. Di Chiara, G. (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol., 393: 295-314.
38. Edelstein, S.J. and Changeux, J.P. (1998) Allosteric transitions of the acetylcholine receptor. Adv. Protein Chem., 51: 121-184.
39. Ego-Stengel, V., Shulz, D.E., Haidarliu, S., Sosnik, R. and Ahissar, E. (2001) Acetylcholine-dependent induction and expression of functional plasticity in the barrel cortex of the adult rat. J. Neurophysiol., 86: 422-437.
40. Faraday, M.M., O'Donoghue, V.A. and Grunberg, N.E. (1999) Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex. Pharmacol. Biochem. Behav., 62: 273-284.
41. Faraday, M.M., Rahman, M.A., Scheufele, P.M. and Grunberg, N.E. (1998) Nicotine administration impairs sensory gating in Long-Evans rats. Pharmacol. Biochem. Behav., 61: 281-289.
42. Feller, M.B., Wellis, D.P., Stellwagen, D., Werblin, F.S. and Shatz, C.J. (1996) Requirement for cholinergic synaptic transmission in the propagation of spontaneous retinal waves. Science, 272: 1182-1187.
43. Fenster, C.P., Whitworth, T.L., Sheffield, E.B., Quick, M.W. and Lester, R.A. (1999) Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J. Neurosci., 19: 4804-4814.
44. Fonck, C.I., Damaj, M.I., Deshpande, P., Bowers, B.J., Wehner, J.M., Nashmi, R., Khakh, B.S., Schwarz, J., Lester, H.A., Labarca, C. (2001) Knock-in mice carrying hypersensitive alpha4 nicotinic receptors: nicotine responses. Soc. Neurosci. Abstr., 27: 2135.
45. Fratiglioni, L. and Wang, H.X. (2000) Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav. Brain Res., 113: 117-120.
46. Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoutos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M.C., Reimherr, F., Wender, P., Yaw, J., Young, D.A., Breese, C.R., Adams, C., Patterson, D., Adler, L.E., Kruglyak, L., Leonard, S. and Byerley, W. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. USA, 94: 587-592.
47. Fuchs, J.L. (1989) [125I]alpha-bungarotoxin binding marks primary sensory area developing rat neocortex. Brain Res., 501: 223-234.
48. Gallagher, M. and Colombo, P.J. (1995) Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol., 5: 161-168.
49. Galzi, J.L. and Changeux, J.P. (1995) Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology, 34: 563-582.
50. Grady, S.R., Meinerz, N.M., Cao, J., Reynolds, A.M., Picciotto, M.R., Changeux, J.P., McIntosh, J.M., Marks, M.J. and Collins, A.C. (2001) Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J. Neurochem., 76: 258-268.
51. Granon, S., Poucet, B., Thinus-Blanc, C., Changeux, J.P. and Vidal, C. (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology (Berl.), 119: 139-144.
52. Granon, S., Faure, P. and Changeux, J. P. (2003) Executive and social behaviors under nicotinic receptor regulation. Proc. Natl. Acad. Sci., USA, (in press).
53. Grenhoff, J., Aston-Jones, G. and Svensson, T.H. (1986) Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol. Scand., 128: 351-358.
54. Groot-Kormelink, P.J., Luyten, W.H., Colquhoun, D. and Sivilotti, L.G. (1998) A reporter mutation approach shows incorporation of the 'orphan' subunit beta3 into a functional nicotinic receptor. J. Biol. Chem., 273: 15317-15320.
55. Hironaka, N., Miyata, H. and Ando, K. (1992) Effects of psychoactive drugs on short-term memory in rats and rhesus monkeys. Jpn. J. Pharmacol., 59: 113-120.
56. Kaiser, S.A., Soliakov, L., Harvey, S.C., Luetje, C.W. and Wonnacott, S. (1998) Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices. J. Neurochem., 70: 1069-1076.
57. Klink, R., de Kerchove d'Exaerde, A., Zoli, M. and Changeux, J.P. (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci., 21: 1452-1463.
58. Koob, G.F. (1996) Hedonic valence, dopamine and motivation. Mol. Psychiatry, 1: 186-189.
59. Kulak, J.M., Nguyen, T.A., Olivera, B.M. and McIntosh, J.M. (1997) Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J. Neurosci., 17: 5263-5270.
60. Labarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M.W., Fonck, C., Nashmi, R., Kofuji, P., Dang, H., Shi, W., Fidan, M., Khakh, B.S., Chen, Z., Bowers, B.J., Boulter, J., Wehner, J.M., Lester, H.A. (2001) Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc. Natl Acad. Sci. USA, 98: 2786-2791.
61. Laudenbach, V., Medja, F., Zoli, M., Rossi, F.M., Evrard, P., Changeux, J.P. and Gressens, P. (2002) Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. Faseb J., 16: 423-425.
62. Le Novère, N., Zoli, M. and Changeux, J.P. (1996) Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci., 8: 2428-2439.
63. Lepore, M. and Franklin, K.B. (1996) N-methyl-D-aspartate lesions of the pedunculopontine nucleus block acquisition and impair maintenance of responding reinforced with brain stimulation. Neuroscience, 71: 147-155.
64. Levin, E.D. (1992) Nicotinic systems and cognitive function. Psychopharmacology (Berl.), 108: 417-431.
65. Levin, E.D., Mead, T., Rezvani, A.H., Rose, J.E., Gallivan, C. and Gross, R. (2000) The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol. Behav., 71: 565-570.
66. Light, G.A. and Braff, D.L. (1999) Is there a critical developmental 'window' for isolation rearing-induced changes in prepulse inhibition of the acoustic startle response? Curr. Psychiatry Rep., 1: 31-40.
67. Luntz-Leybman, V., Bickford, P.C. and Freedman, R. (1992) Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res., 587: 130-136.
68. Marubio, L.M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Lena, C., Le Novere, N., de Kerchove d'Exaerde, A., Huchet, M., Damaj, M.I. and Changeux, J.P. (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature, 398: 805-810.
69. Marubio, L.M., Gardier A.M. Durier, S. David, D., Klink, R. del Mar Arroyo-Jimenez, M. McIntosh, J.M., Rossi, F.M.R., Champtiaux, N., Zoli, M. and Changeux, J.P. (2003) Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur. J. Neurosci., 17: 1329-1337.
70. McGehee, D.S. and Role, L.W. (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol., 57: 521-546.
71. McEwen, B.S. and Sapolsky, R.M. (1995) Stress and cognitive function. Curr. Opin. Neurobiol., 5: 205-216.
72. Mega, M.S. (2000) The cholinergic deficit in Alzheimer's disease: impact on cognition, behaviour and function. Int. J. Neuropsychopharmacol., 3: 3-12.
73. Moser, P.C., Hitchcock, J.M., Lister, S. and Moran, P.M. (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res. Brain Res. Rev., 33: 275-307.
74. Nadeau, J.H. (2001) Modifier genes in mice and humans. Nat. Rev. Genet., 2: 165-174.
75. Neves-Pereira, M., Bassett, A.S., Honer, W.G., Lang, D., King, N.A. and Kennedy, J.L. (1998) No evidence for linkage of the CHRNA7 gene region in Canadian schizophrenia families. Am. J. Med. Genet., 81: 361-363.
76. Newhouse, P.A., Potter, A. and Levin, E.D. (1997) Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging, 11: 206-228.
77. Nilsson, O.G., Strecker, R.E., Daszuta, A. and Bjorklund, A. (1988) Combined cholinergic and serotonergic denervation of the forebrain produces severe deficits in a spatial learning task in the rat. Brain Res., 453: 235-240.
78. Nisell, M., Nomikos, G.G. and Svensson, T.H. (1994) Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16: 36-44.
79. Nomikos, G.G., Schilstrom, B., Hildebrand, B.E., Panagis, G., Grenhoff, J. and Svensson, T.H. (2000) Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness. Behav. Brain Res., 113: 97-103.
80. Nordberg, A. (2001) Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol. Psychiatry, 49: 200-210.
81. Ochoa, E.L. (1994) Nicotine-related brain disorders: the neurobiological basis of nicotine dependence. Cell Mol. Neurobiol., 14: 195-225.
82. Olivier, B., Leahy, C., Mullen, T., Paylor, R., Groppi, V.E., Sarnyai, Z. and Brunner, D. (2001) The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?. Psychopharmacology (Berl.), 156: 284-290.
83. Olmstead, M.C. and Franklin, K.B. (1994) Lesions of the pedunculopontine tegmental nucleus block drug-induced reinforcement but not amphetamine-induced locomotion. Brain Res., 638: 29-35.
84. Olmstead, M.C., Inglis, W.L., Bordeaux, C.P., Clarke, E.J., Wallum, N.P., Everitt, B.J. and Robbins, T.W. (1999) Lesions of the pedunculopontine tegmental nucleus increase sucrose consumption but do not affect discrimination or contrast effects. Behav. Neurosci., 113: 732-743.
85. Orr-Urtreger, A., Broide, R.S., Kasten, M.R., Dang, H., Dani, J.A., Beaudet, A.L. and Patrick, J.W. (2000) Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J. Neurochem., 74: 2154-2166.
86. Orr-Urtreger, A., Goldner, F.M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J.A., Patrick, J.W. and Beaudet, A.L. (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci., 17: 9165-9171.
87. Paylor, R., Nguyen, M., Crawley, J.N., Patrick, J., Beaudet, A. and Orr-Urtreger, A. (1998) Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn. Mem., 5: 302-316.
88. Penn, A.A., Riquelme, P.A., Feller, M.B. and Shatz, C.J. (1998) Competition in retinogeniculate patterning driven by spontaneous activity. Science, 279: 2108-2112.
89. Phillips, H.A., Favre, I., Kirkpatrick, M., Zuberi, S.M., Goudie, D., Heron, S.E., Scheffer, I.E., Sutherland, G.R., Berkovic, S.F., Bertrand, D., Mulley, J.C. (2001) CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet., 68: 225-231.
90. Picciotto, M.R., Zoli, M., Lena, C., Bessis, A., Lallemand, Y., LeNovere, N., Vincent, P., Pich, E.M., Brulet, P., Changeux, J.P. (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature, 374: 65-67.
91. Picciotto, M.R., Zoli, M., Rimondini, R., Lena, C., Marubio, L.M., Pich, E.M., Fuxe, K. and Changeux, J.P. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391: 173-177.
92. Pidoplichko, V.I., DeBiasi, M., Williams, J.T. and Dani, J.A. (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390: 401-404.
93. Pontieri, F.E., Tanda, G., Orzi, F. and Di Chiara, G. (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382: 255-257.
94. Pugh, P.C. and Berg, D.K. (1994) Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J. Neurosci., 14: 889-896.
95. Ramirez-Latorre, J., Yu, C.R., Qu, X., Perin, F., Karlin, A. and Role, L. (1996) Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels. Nature, 380: 347-351.
96. Reid, M.S., Mickalian, J.D., Delucchi, K.L. and Berger, S.P. (1999) A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology, 20: 297-307.
97. Renshaw, G., Rigby, P., Self, G., Lamb, A. and Goldie, R. (1993) Exogenously administered alpha-bungarotoxin binds to embryonic chick spinal cord: implications for the toxin-induced arrest of naturally motoneuron death. Neuroscience, 53: 1163-1172.
98. Riley, B.P., Makoff, A., Mogudi-Carter, M., Jenkins, T., Williamson, R., Collier, D. and Murray, R. (2000) Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am. J. Med. Genet., 96: 196-201.
99. Rochford, J., Sen, A.P. and Quirion, R. (1996) Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat. J. Pharmacol. Exp. Ther., 277: 1267-1275.
100. Robbins, T.W., McAlonan, G., Muir, J.L. and Everitt, B.J. (1997) Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease. Behav. Brain Res., 83: 15-23.
101. Roerig, B. and Feller, M.B. (2000) Neurotransmitters and gap junctions in developing neural circuits. Brain Res. Brain Res. Rev., 32: 86-114.
102. Role, L.W. and Berg, D.K. (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16: 1077-1085.
103. Ross, S.A., Wong, J.Y., Clifford, J.J., Kinsella, A., Massalas, J.S., Horne, M.K., Scheffer, I.E., Kola, I., Waddington, J.L., Berkovic, S.F., Drago, J. (2000) Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J. Neurosci., 20: 6431-6441.
104. Rossi, F.M., Pizzorusso, T., Porciatti, V., Marubio, L.M., Maffei, L. and Changeux, J.P. (2001) Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc. Natl Acad. Sci. USA, 98: 6453-6458.
105. Ryan, R.E., Ross, S.A., Drago, J. and Loiacono, R.E. (2001) Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. Br. J. Pharmacol., 132: 1650-1656.
106. Sachdev, R.N., Lu, S.M., Wiley, R.G. and Ebner, F.F. (1998) Role of the basal forebrain cholinergic projection in somatosensory cortical plasticity. J. Neurophysiol., 79: 3216-3228.
107. Sapolsky, R.M. (1996) Why stress is bad for your brain. Science, 273: 749-750.
108. Sarter, M. (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?. Psychopharmacology (Berl.), 114: 539-550.
109. Schultz, W. (1997) Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol., 7: 191-197.
110. Selkoe, D.J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol., 10: 373-403.
111. Sharples, C.G., Kaiser, S., Soliakov, L., Marks, M.J., Collins, A.C., Washburn, M., Wright, E., Spencer, J.A., Gallagher, T., Whiteaker, P., Wonnacott, S. (2000) UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J. Neurosci., 20: 2783-2791.
112. Simosky, J.K., Stevens, K.E., Kem, W.R. and Freedman, R. (2001) Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol. Psychiatry, 50: 493-500.
113. So, K.F., Campbell, G. and Lieberman, A.R. (1990) Development of the mammalian retinogeniculate pathway: target finding, transient synapses and binocular segregation. J. Exp. Biol., 153: 85-104.
114. Stefurak, T.L. and van der Kooy, D. (1994) Tegmental pedunculopontine lesions in rats decrease saccharin's rewarding effects but not its memory-improving effect. Behav. Neurosci., 108: 972-980.
115. Stevens, K.E. and Wear, K.D. (1997) Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol. Biochem. Behav., 57: 869-874.
116. Stevens, K.E., Freedman, R., Collins, A.C., Hall, M., Leonard, S., Marks, M.J. and Rose, G.M. (1996) Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors inbred mouse strains. Neuropsychopharmacology, 15: 152-162.
117. Stevens, K.E., Kem, W.R., Mahnir, V.M. and Freedman, R. (1998) Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl.), 136: 320-327.
118. Sutor, B. and Zolles, G. (2001) Neuronal nicotinic acetylcholine receptors and autosomal dominant nocturnal frontal lobe epilepsy: a critical review. Pflugers Arch., 442: 642-651.
119. Thornton, J.C., Dawe, S., Lee, C., Capstick, C., Corr, P.J., Cotter, P., Frangou, S., Gray, N.S., Russell, M.A., Gray, J.A. (1996) Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl.), 127: 164-173.
120. Tilson, H.A., McLamb, R.L., Shaw, S., Rogers, B.C., Pediaditakis, P. and Cook, L. (1988) Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents. Brain Res., 438: 83-94.
121. Vailati, S., Moretti, M., Balestra, B., McIntosh, M., Clementi, F. and Gotti, C. (2000) beta3 subunit is present in different nicotinic receptor subtypes in chick retina. Eur. J. Pharmacol., 393: 23-30.
122. Vernallis, A.B., Conroy, W.G. and Berg, D.K. (1993) Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron, 10: 451-464.
123. Vetter, D.E., Liberman, M.C., Mann, J., Barhanin, J., Boulter, J., Brown, M.C., Saffiote-Kolman, J., Heinemann, S.F. and Elgoyhen, A.B. (1999) Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron, 23: 93-103.
124. Whiteaker, P., Peterson, C.G., Xu, W., McIntosh, J.M., Paylor, R., Beaudet, A.L., Collins, A.C. and Marks, M.J. (2002) Involvement of the alpha3 subunit in central nicotinic binding populations. J. Neurosci., 22: 2522-2529.
125. Wong, R.O. (1999) Retinal waves and visual system development. Annu. Rev. Neurosci., 22: 29-47.
126. Wonnacott, S. (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci., 11: 216-219.
127. Xu, W., Gelber, S., Orr-Urtreger, A., Armstrong, D., Lewis, R.A., Ou, C.N., Patrick, J., Role, L., De Biasi, M., Beaudet, A.L. (1999) Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA, 96: 5746-5751.
128. Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutcliffe, C.B., Armstrong, D., Patrick, J.W., Role, L.W., Beaudet, A.L., De Biasi, M. (1999) Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci., 19: 9298-9305.
129. Zachariou, V., Caldarone, B.J., Weathers-Lowin, A., George, T.P., Elsworth, J.D., Roth, R.H., Changeux, J.P. and Picciotto, M.R. (2001) Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology, 24: 576-589.
130. Zhang, X., Liu, C., Miao, H., Gong, Z.H. and Nordberg, A. (1998) Postnatal changes of nicotinic acetylcholine receptor alpha 2, alpha 3, alpha 4, alpha 7 and beta 2 subunits genes expression in rat brain. Int. J. Dev. Neurosci., 16: 507-518.
131. Zheng, J.Q., Felder, M., Connor, J.A. and Poo, M.M. (1994) Turning of nerve growth cones induced by neurotransmitters. Nature, 368: 140-144.
132. Zhou, F.M., Liang, Y. and Dani, J.A. (2001) Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci., 4: 1224-1229.
133. Zoli, M., Le Novere, N., Hill, J.A., Jr. and Changeux, J.P. (1995) Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci., 15: 1912-1939.
134. Zoli, M., Picciotto, M.R., Ferrari, R., Cocchi, D. and Changeux, J.P. (1999) Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J., 18: 1235-1244.